264 related articles for article (PubMed ID: 16997964)
21. A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
Saito M; Yamamoto S; Ozaki K; Tomioka Y; Suyama H; Morimatsu M; Nishijima KI; Yoshida SI; Ono E
Microb Pathog; 2016 Oct; 99():106-110. PubMed ID: 27544323
[TBL] [Abstract][Full Text] [Related]
22. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
Chaffin DO; Mentele LM; Rubens CE
J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
[TBL] [Abstract][Full Text] [Related]
23. Siglecs, sialic acids and innate immunity.
Crocker PR; Varki A
Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
[TBL] [Abstract][Full Text] [Related]
24. Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.
Alhhazmi A; Pandey A; Tyrrell GJ
J Clin Microbiol; 2017 Sep; 55(9):2637-2650. PubMed ID: 28615470
[TBL] [Abstract][Full Text] [Related]
25. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Cao H; Crocker PR
Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
[TBL] [Abstract][Full Text] [Related]
26. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions.
Connolly NP; Jones M; Watt SM
Br J Haematol; 2002 Oct; 119(1):221-38. PubMed ID: 12358929
[TBL] [Abstract][Full Text] [Related]
27. [Functions of sialic acids-binding lectins, Siglecs].
Yamaji T; Hashimoto Y
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1098-105. PubMed ID: 12807015
[No Abstract] [Full Text] [Related]
28. The interplay between Siglecs and sialylated pathogens.
Chang YC; Nizet V
Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
[TBL] [Abstract][Full Text] [Related]
29. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
Albanyan EA; Edwards MS
Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
[TBL] [Abstract][Full Text] [Related]
30. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
31. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
32. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
[TBL] [Abstract][Full Text] [Related]
33. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
Crocker PR
Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
[TBL] [Abstract][Full Text] [Related]
34. Siglecs--the major subfamily of I-type lectins.
Varki A; Angata T
Glycobiology; 2006 Jan; 16(1):1R-27R. PubMed ID: 16014749
[TBL] [Abstract][Full Text] [Related]
35. Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association.
Kjaer TR; Hansen AG; Sørensen UB; Nielsen O; Thiel S; Jensenius JC
J Leukoc Biol; 2011 Sep; 90(3):425-37. PubMed ID: 21730084
[TBL] [Abstract][Full Text] [Related]
36. Human-specific regulation of alpha 2-6-linked sialic acids.
Gagneux P; Cheriyan M; Hurtado-Ziola N; van der Linden EC; Anderson D; McClure H; Varki A; Varki NM
J Biol Chem; 2003 Nov; 278(48):48245-50. PubMed ID: 14500706
[TBL] [Abstract][Full Text] [Related]
37. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus.
Chang YC; Olson J; Louie A; Crocker PR; Varki A; Nizet V
J Mol Med (Berl); 2014 Sep; 92(9):951-9. PubMed ID: 24788876
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
Lock K; Zhang J; Lu J; Lee SH; Crocker PR
Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
[TBL] [Abstract][Full Text] [Related]
39. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
McMillan SJ; Crocker PR
Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
[TBL] [Abstract][Full Text] [Related]
40. The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design.
Attrill H; Takazawa H; Witt S; Kelm S; Isecke R; Brossmer R; Ando T; Ishida H; Kiso M; Crocker PR; van Aalten DM
Biochem J; 2006 Jul; 397(2):271-8. PubMed ID: 16623661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
